ADHD

Andrew J. Cutler, MD, and Rakesh Jain, MD, MPH, comment on comorbid psychiatric disorders complicating the diagnostic process for ADHD and review unmet needs.

A review of common signs and symptoms prompting testing for ADHD and approaching ADHD diagnosis in adults.

Updates in the AAP (American Academy of Pediatrics) and SDBP (Society for Developmental and Behavioral Pediatrics) guidelines for the assessment, evaluation, and treatment of ADHD in children and adolescents.

BBT was compared to assisted referral to community outpatient mental health care.

Researchers see differences in how COVID-19 attacks the brain in comparison to the influenza virus that caused the 1918 pandemic.

Rakesh Jain, MD, MPH, comments on factors pre-disposing children and adults to ADHD and the impact of disease on patients’ and caregivers’ quality of life (QoL).

Andrew J. Cutler, MD, provides an overview of the different presentations of attention deficit hyperactivity disorders (ADHD) and the clinical burden on children and adults.

The immediate release d-MPH treatment is indicated for ADHD patients at least 6 years old.

Researchers find an increased risk of offspring ADHD symptoms due to maternal anxiety.

Researchers found a significant association between polygenic risk scores for ADHD and reaction time variability, but not commission errors.

Recent clinical trials have shown positive topline results for SPN-812.

Dr. Cortese explains how more data could improve ADHD care.

Dr. Cortese discusses the current gaps in ADHD treatment.

Dr. Matthew Brams presented new data showing the efficacy of CTx-1301 for ADHD.

CTx-1301's formulation enables 3 different doses within 1 pill for ADHD.

Researchers are prepared a phase 3 trial testing the treatment in adults with ADHD.

The role of many in psychiatry has changed during the COVID-19 pandemic.

Such scores could provide insight into the significant comorbidity rate of ADHD and other youth mood and emotional dysregulation issues.

Personalized, daily self-reporting for patients could influence future therapeutic strategies.

Randomized controlled trials are needed to evaluate their efficacy in comparison with in-person group meetings.

Investigators have observed a development-related shift in risks from teenaged ADHD and alcohol use risks in the patients' 30s.

A pair of researchers present plans to improve collaboration with other professionals in ADHD.

The likelihood of smoking addiction is associated with traits also closely associated with worsened ADHD.

An ADHD coach can work on more goal-based plans for individuals with ADHD.

A study finds that secondhand smoking may have a greater negative impact on children than prenatal smoke exposure.

There is a high association between parents' concerns of autism spectrum disorder in their children and identified symptoms of ADHD.

There is currently no approved treatment for fragile X syndrome.

Current estimates indicate that non-adherence to stimulants is as high as 87%.

New research expands on the understood link between sleep and ADHD-related behavior, and gives clinicians new therapeutic targets.

Though the correlation is concerning for at-risk groups, experts believe it could inform individualized psychiatric care during crises.